Melody Barnes - Ventas Independent Director
| VTR Stock | USD 67.71 0.13 0.19% |
Director
Ms. Melody C. Barnes is Independent Director of the company. She is the CoFounder and Principal of MB Squared Solutions, LLC, a domestic policy strategy firm, and Chair of the Aspen Institute Forum for Community Solutions. Since 2012, she has also served as Vice Provost, Global Student Leadership Initiatives and a Senior Fellow at the Robert F. Wagner School of Public Service at New York University. Ms. Barnes currently serves as a director of Booz Allen Hamilton Inc. . From January 2009 to January 2012, Ms. Barnes served in the White House as Director of the Domestic Policy Council. In this role, she provided policy and strategic advice to President Obama and coordinated the domestic policymaking process for her administration. Before joining the White House, she served as the Senior Domestic Policy Advisor for thenSenator Obamas 2008 presidential campaign since 2014.
| Age | 56 |
| Tenure | 11 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.018 % which means that on every $100 spent on assets, it made $0.018 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/21/2025, Return On Tangible Assets is likely to drop to 0. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Ronald Marston | Global Medical REIT | 78 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Barbara Hill | Omega Healthcare Investors | 67 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Robert McCabe | National Health Investors | 70 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Matthew Cypher | Global Medical REIT | 44 | |
| Roscoe Moore | Global Medical REIT | 76 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Henry Cole | Global Medical REIT | 76 | |
| Colleen Schaller | National Health Investors | N/A | |
| Burke Whitman | Omega Healthcare Investors | 64 | |
| James Jobe | National Health Investors | 59 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
Management Performance
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 42.65 B | ||||
| Shares Outstanding | 437.14 M | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 99.90 % | ||||
| Number Of Shares Shorted | 12.45 M | ||||
| Price To Earning | 909.80 X |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.